Log in to save to my catalogue

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: pr...

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: pr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6d7f288287f40648bb639f0ca3afefa

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data

About this item

Full title

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data

Publisher

England: BioMed Central

Journal title

Systematic reviews, 2017-04, Vol.6 (1), p.87-87, Article 87

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder caused by deficiency in acid beta-glucosidase. GD exhibits a wide clinical spectrum of disease severity with an unpredictable natural course. Plasma chitotriosidase activity and CC chemokine ligand 18 (CCL18) have been exchangeably used for monitoring GD activity and response...

Alternative Titles

Full title

Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d6d7f288287f40648bb639f0ca3afefa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6d7f288287f40648bb639f0ca3afefa

Other Identifiers

ISSN

2046-4053

E-ISSN

2046-4053

DOI

10.1186/s13643-017-0483-x

How to access this item